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We have developed yeast artificial chromosome (YAC) transgenic mice expressing normal (YAC18) and mutant
(YAC46 or YAC72) human huntingtin (htt), in a developmental- and tissue-specific manner, that is identical to
endogenous htt. YAC72 mice develop selective degeneration of medium spiny projection neurons in the lateral
striatum, similar to what is observed in Huntington disease. Mutant human htt expressed by YAC transgenes can
compensate for the absence of endogenous htt and can rescue the embryonic lethality that characterizes mice
homozygous for targeted disruption of the endogenous Hdh gene (5/5). YAC72 mice lacking endogenous htt
(YAC72 5/5) manifest a novel phenotype characterized by infertility, testicular atrophy, aspermia, and massive
apoptotic cell death in the testes. The testicular cell death in YAC72 5/5 mice can be markedly reduced by
increasing endogenous htt levels. YAC72 mice with equivalent levels of both wild-type and mutant htt (YAC72
+/+) breed normally and have no evidence of increased testicular cell death. Similar findings are seen in YAC46
5/5 mice compared with YAC46 +/+ mice, in which wild-type htt can completely counteract the proapoptotic
effects of mutant htt. YAC18 5/5 mice display no evidence of increased cellular apoptosis, even in the complete
absence of endogenous htt, demonstrating that the massive cellular apoptosis observed in YAC46 5/5 mice and
YAC72 5/5 mice is polyglutamine-mediated toxicity from the mutant transgene. These data provide the first
direct in vivo evidence of a role for wild-type htt in decreasing the cellular toxicity of mutant htt.
Introduction
The mutation in Huntington disease (HD [MIM
143100; also see The Genome Database [accession num-
ber 119307]) is the expansion of a CAG-trinucleotide
repeat in the first exon of the HD gene (Huntington
Disease Collaborative Research Group 1993). Alleles
containing expansions 135 CAG repeats are associated
with the clinical phenotype of HD, with an earlier age
at onset occurring with higher CAG-repeat sizes (An-
drew et al. 1993). The mutation in the HD gene pro-
duces a protein, huntingtin (htt), with an expanded po-
lyglutamine tract. Proteolytic cleavage of htt, possibly
by caspases, produces N-terminal htt fragments con-
taining the expanded polyglutamine tract (Goldberg et
al. 1996; Wellington et al. 1998, 2000). N-terminal frag-
ments of mutant expanded htt have altered cellular in-
teractions (Li et al. 1995; Bao et al. 1996; Burke et al.
1996; Kalchman et al. 1996, 1997; Wanker et al. 1997)
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and nuclear localization (Davies et al. 1997; DiFiglia et
al. 1997; Becher et al. 1998; Hackam et al. 1998; Gu-
tekunst et al. 1999; Hodgson et al. 1999; Schilling et al.
1999; Li et al. 2000; Wheeler et al. 2000) and, in a
variety of in vitro model systems, are directly toxic to
neuronal cells (Hackam et al. 1998; Martindale et al.
1998; Sandou et al. 1998). These htt fragments are also
prone to intracellular aggregation and inclusion for-
mation (Cooper et al. 1998; Hackam et al. 1998; Mar-
tindale et al. 1998), although the relevance of htt ag-
gregation to the pathogenesis of HD remains unclear
(reviewed in Sisoda 1998). The expansion of polyglu-
tamine residues in htt has been proposed to result in a
novel toxic gain of function of the mutant protein (Mac-
Donald and Gusella 1996), but alterations in normal
endogenous htt levels and loss of htt function may also
play a role in the pathogenesis of HD.
htt is a large protein of uncertain function that is
ubiquitously expressed in many tissues of the body but
that is at its highest levels in brain and testis (Sharp and
Ross 1996). Mice homozygous for targeted disruption
of Hdh (/), the murine homologue of the HD gene,
die at embryonic day 7.5 (Duyao et al. 1995; Nasir et
al. 1995; Zeitlin et al. 1995). Mice with decreased levels
of htt after targeted insertion of a neo construct into
the Hdh gene have aberrant brain development and
perinatal lethality (White et al. 1997). Mice heterozy-
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gous for targeted disruption of the Hdh gene (/)
express half the normal levels of endogenous htt and
develop neuronal degeneration in the basal ganglia dur-
ing adulthood (O’Kusky et al. 1999). Together, these
results suggest that htt may normally be involved both
in embryogenesis and in neuronal survival in the adult.
Recently, we demonstrated that wild-type htt has anti-
apoptotic properties in vitro (Rigamonti et al. 2000). To
assess the ability of wild-type htt to modulate the toxicity
of mutant htt in vivo, we developed a transgenic mouse
model in which the phenotypic effects that varying en-
dogenous htt levels have on mice expressing transgenic
htt can be assessed.
Our laboratory has recently produced YAC mice
transgenic for the entire genomic region of the human
HD gene, including all its regulatory sequences (Hodg-
son et al. 1999). Human htt is expressed appropriately
during development in YAC transgenic mice, as dem-
onstrated by the ability of the human transgene to rescue
the embryonic lethality of Hdh-nullizygous mice (/)
(Hodgson et al. 1996). Appropriate control of tissue
specificity was confirmed by the identical expression
patterns of endogenous and human transgenic htt, by
western blot analysis and subcellular localization stud-
ies (Hodgson et al. 1996, 1999).
YAC transgenic mice have been generated that express
human htt with 18 polyglutamines (YAC18), correspond-
ing to a CAG-repeat length observed in unaffected per-
sons; 46 polyglutamines (YAC46), corresponding to a
CAG-repeat length observed in patients with adult-onset
HD; and 72 polyglutamines (YAC72), corresponding to
a repeat length causing juvenile-onset HD (Hodgson et
al. 1999). These mice express similar levels of transgenic
human htt, which differ only in polyglutamine-expansion
length. Up to 24 mo of age, YAC18 mice have no ob-
servable phenotype, indicating that human htt with a
polyglutamine tract of normal length is not pathogenic
in mice. However, mice transgenic for mutant htt with
an expanded polyglutamine develop a progressive phe-
notype characterized by behavioral, cellular, and neu-
ropathological abnormalities similar to those observed in
HD (Hodgson et al. 1999).
When crossed to the Hdh-nullizygous background,
YAC transgenic mice survive normally into adulthood
(designation “YAC /”). These crosses provide a sys-
tem in which one can examine the role of wild-type htt
in the modulation of the cellular toxicity of mutant htt
in vivo. In this study, we demonstrate that mutant hu-
man htt causes increased apoptotic cell death in the
testes of transgenic mice expressing no endogenous htt.
This proapoptotic effect of mutant htt can be completely
inhibited by increased levels of murine wild-type htt,
providing the first in vivo evidence that wild-type htt
can reduce the toxicity of mutant htt.
Material and Methods
Generation of Experimental Mice
YAC transgenic mice (FVB/NJ strain) from lines 29
(YAC18), 668 (YAC46), and 2511 (YAC72) were bred
with mice heterozygous for targeted disruption of the
endogenous mouse Hdh gene (C57BL6 strain), to pro-
duce F1-generation hybrid mice. F1 hybrid mice positive
for the YAC transgene and heterozygous for the Hdh
gene were then bred to produce litters of F2 experimental
mice, as described elsewhere (Hodgson et al. 1996). All
the F2 offspring of these matings were genotyped and
used to generate experimental data. We also bred se-
lected F2 mice, to examine mating behavior, breeding
success rates, and to obtain postcoital sperm counts.
Genotyping was performed, by standard PCR-based
techniques, on genomic DNA from tail clippings prepared
by phenol-chloroform extraction (Hodgson et al. 1996).
Protein expression was determined by western blot in
which 200 mg of total protein from homogenized testes
was loaded onto a low-bis acrylamide gel, run at 100 V
for 2 h and at 200 V for 3 h before being transferred to
polyvinylidene fluoride membranes. Blots were probed
with anti-htt antibody (HD3 at a diltution of 1/1,000;
Gutekunst et al. 1999) and were detected by enhanced
chemiluminescence immunodetection (Amersham).
Fertility, Mating Behavior, and Sperm Analysis
To assess breeding success, adult male mice of each
genotype were placed in breeding cages with single FVB/
NJ female mice for 4 mo (a minimum of three male
mice were tested per genotype). The total duration of
time spent in breeding cages and the total number of
live-born litters was recorded for each mouse. Failure to
produce any litters after a cumulative breeding duration
of 4 mo was considered to represent male infertility.
Newwild-type females with previous successful breeding
experience were placed in breeding cages containing in-
fertile males, to control for any contribution of the fe-
male partner. YAC72 / male mice (i.e., those ex-
pressing human htt with 72 polyglutamines and no
endogenous murine htt), YAC72 / male mice (i.e.,
those expressing human htt with 72 polyglutamines on
a background of half the normal levels of endogenous
murine htt), and YAC72 / male mice (i.e., those ex-
pressing human htt with 72 polyglutamines on a back-
ground of normal levels of endogenous murine htt) were
placed in breeding cages with pseudopregnant FVB/NJ
females, to assess male sexual behavior and postcoital
sperm counts. These wild-type female mice were injected
with 0.1 ml of pregnant mare serum (Sigma) 48 h prior
to stimulation with 10 IU of human chorionic gonad-
otropin (Sigma) and placement in breeding cages with
the transgenic males. Mounting behavior of male mice
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was scored for 2–3 h after placement in breeding cages,
and plug formation was determined by manual inspec-
tion of the female mice the following morning.
Postcoital sperm counts were determined on the basis
of the extracted uterus of all female mice that had evi-
dence of plug formation after breeding with male trans-
genic mice. After breeding, the plugged female mice were
anesthetized, and the uterus and oviducts were removed
in toto and gently were opened in a sterile 12-well tissue-
culture plate; 0.5 ml of sterile saline was used to flush
the uterus, and the resultant solution was collected and
examined microscopically for the presence of sperm. To
obtain quantitative sperm counts, the testes and epidid-
ymides of YAC72 / mice, YAC72 / mice, and
YAC72 / mice ( mice per genotype) were re-np 6
moved and immediately weighed. The tissues were then
sectioned and placed in tubes containing 0.5 ml of ster-
ile saline. Total numbers of morphologically normal
sperm were manually counted, by a hemacytometer
(Hausser), for three samples from each tissue. The he-
macytometer counts for each tissue were averaged, and
the total counts per milliliter were calculated. Results
are expressed as average  SEM sperm count per mil-
liliter, and significance was determined by Students t-
test.
Histological and Ultrastructural Analysis
Testes were removed from anesthetized animals and
immediately were placed in fixative (1.5% paraformal-
dehyde, 1.5% glutaraldehyde, 0.1M sodium cacodylate,
pH 7.3). The capsules were nicked with a scalpel, and
then the organs were left to fix for ∼1 h. The testes were
cut into small pieces and were fixed for an additional
hour. The pieces were washed with buffer, postfixed in
buffered 1% OsO4 on ice for 1 h, washed with dH20,
and stained en bloc in 1% aqueous uranyl acetate. The
samples were washed with dH20, dehydrated through a
graded concentration series of ethyl alcohols, and then
embedded in JEMBED 812 (J. B. EM Services).
For histological analysis, thick (1 mm) sections were
stained with toluidine blue and were evaluated by a Zeiss
Axiophot microscope. For ultrastructural analysis, thin
sections were cut on an ultramicrotome, stained with
lead citrate and uranyl acetate, and then viewed and
photographed by a Philips 300 electron microscope op-
erated at 60 kV.
TUNEL labeling (Boehringer Mannheim) was per-
formed, by standard techniques, on frozen sections of
testes that were lightly immersion fixed in 3% parafor-
maldehyde. After removal of the testes, mice were in-
jected with heparin and were perfused transcardially
with 3% paraformaldehyde and 0.15% glutaraldehyde
in phosphate buffer (pH 7.4). Brains were then removed
and postfixed in 3% paraformaldehyde overnight.
Immunocytochemistry
Testes were excised from anesthetized animals, the
capsules were cut open with a scalpel, and the organs
were immersion fixed (3% paraformaldehyde, 150 mM
NaCl, 5 mM KCl, 3.2 mMNa2HPO4, 0.8 mM KH2PO4,
pH 7.3) for 1–2 h. After fixation, the testes were washed
three times (10 min each wash) with PBS (150 mM
NaCl, 5 mM KCl, 3.2 mMNa2HPO4, 0.8 mM KH2PO4,
pH 7.3) and then were frozen in Tissue-Tek embedding
medium (Sakura) compound and sectioned on a cryo-
stat. Sections (10 mm thick) were collected on polylysine-
coated slides, and then the slides were immediately
plunged into cold (20C) acetone for 5 min; then the
slides were air-dried.
Sections were rehydrated for 30 min in TPBS (PBS,
0.05% Tween-20, 0.1% BSA) containing 5% normal
goat serum (NGS) and then were incubated for 1 h at
37C with primary antiserum diluted 1:100 (HD3) with
TPBS containing 1% NGS. Sections were washed three
times (10 min each wash) with TPBS and then were
incubated for 1 h at 37C with secondary antibody (goat
anti-rabbit conjugated to Texas red) diluted 1:100 in
TPBS. Sections again were washed with TPBS and then
were mounted in Vetashield (Vector Laboratories) and
were viewed by a Zeiss Axiophot microscope fitted with
the appropriate fluorescence filter sets. Controls con-
sisted of replacement of (1) the primary antibody by the
same concentration of normal rat IgG (as the control
for primary antibody), (2) the primary antibody with
buffer alone (as the control for secondary antibody), and
(3) the primary and secondary antibodies with buffer
alone (as the control for autofluorescence).
Results
Rescue of the Hdh /Lethal Phenotype by YAC
Transgenes Expressing Mutant Human htt
We generated YAC transgenic mice expressing normal
(YAC18) or mutant (YAC46 or YAC72) human htt in
the absence of endogenous mouse htt (Hdh/). Figure
1A demonstrates the genotypes of several offspring from
a cross between two mice heterozygous for targeted dis-
ruption of the Hdh gene, one of which also carried the
YAC72 transgene (YAC72/). Mice with targeted dis-
ruption of both alleles of the Hdh gene can be rescued
from the embryonic lethal phenotype by the YAC trans-
gene expressing mutant htt with 72 CAG repeats
(YAC72 /). In this litter, mice were generated with
the YAC72 transgene and either 100% of the normal
level of endogenous htt (YAC72 /), 50% of the nor-
mal level of endogenous htt (YAC72 /), or complete
absence of endogenous htt (YAC72/). A mouse lack-
ing the YAC72 transgene but heterozygous for endog-
enous htt is also shown (fig. 1A, , /). No Hdh
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Figure 1 Rescue of the Hdh-nullizygous lethal phenotype by YAC transgenes expressing mutant htt. Resultant genotypes for the F2
offspring of a cross between a YAC72 transgene–positive, Hdh-heterozygous mouse (, / genotype) and a YAC72 transgene–negative,Hdh-
heterozygous mouse (, / genotype) are shown (A). The upper PCR bands represent the presence or absence of the YAC transgene, and
the lower bands represent the state of the endogenous Hdh gene. The mouse represented in the second lane has the YAC72 transgene but lacks
the endogenous Hdh gene (, / genotype). This mouse demonstrates that mutant human htt expression from our YAC transgene rescued
the Hdh-nullizygous state. Mice with targeted disruption of the Hdh gene were rescued from the embryonic lethal phenotype equally by all
three of the YAC transgenes described in the present study. The F2 offspring of our experimental breedings had the expected 1:2:1 ratio of
genotypes for all of the YAC transgenes examined (B). Western blot analysis of htt-protein expression (C) confirmed the absence of endogenous
htt protein in Hdh-nullizygous mice (/), compared with wild-type mice (/), and demonstrated similar levels of human transgenic htt
expression in YAC18-, YAC46-, and YAC72-rescued Hdh-nullizygous mice (, /). Average testicular weight (D) and epididymal sperm
counts (E) for YAC72 / mice, YAC72 / mice, and YAC72 / mice at age 4 mo are shown. YAC72 / mice had significant testicular
atrophy ( ) and decreased sperm counts ( ), compared with YAC72 / mice and YAC72 / mice.5 5P ! 10 P ! 10
/ mice were generated in the absence of the YAC
transgene, consistent with the previous finding thatHdh-
nullizygous mice are not viable (Duyao et al. 1995; Nasir
et al. 1995; Zeitlin et al. 1995). The F2 offspring of our
experimental breedings had the expected 1:2:1 ratio of
genotypes for all of the YAC transgenes examined (fig.
1B), demonstrating that both the normal (YAC18) and
mutant (YAC46 or YAC72) humanHD transgenes com-
pensated for the lack of endogenous murine htt in Hdh
/ mice equally.
Levels of htt Expression in YAC Transgene–Rescued
Hdh / Mice
Levels of the transgenic and wild-type htt protein for
YAC18 (line 29), YAC46 (line 668), and YAC72 (line
2511) Hdh / mice were measured by western blot
analysis using an antibody recognizing both human and
mouse htt (Hodgson et al. 1996). The human transgenic
protein is expressed at similar levels in the YAC18 mice,
YAC46mice, and YAC72mice used in these experiments
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(fig. 1C). This result was replicated in three different
western blots, and densitometric quantification of the
transgenic protein level from these blots revealed a 1:1
ratio of transgenic versus endogenous htt levels in these
mice. Transgenic protein levels from YAC18 mice av-
eraged 102% of wild-type htt, YAC46 averaged 99%
of wild-type htt, and YAC72 averaged 100% of wild-
type htt. These three lines of YAC transgenic mice were
selected for these experiments because they expressed
identical levels of transgenic protein, differing only in
the length of the CAG repeat.
Infertility of Mice Expressing Mutant htt
Expression of mutant (YAC46 and YAC72)—but not
of wild-type (YAC18)—transgenic htt in the absence of
endogenous htt leads to a novel phenotype that was
initially identified by the observation that male Hdh
/ mice were unable to breed. We attempted to breed
YAC46 / males and YAC72 / males with wild-
type females for extended periods, with no success (i.e.,
no offspring were generated). Female littermates with
the same genotype (YAC46 / or YAC72 /) had
normal fertility when bred with wild-type mice. Male
YAC72 / mice had normal secondary sexual char-
acteristics and, when placed in cages with female wild-
type mice, displayed identical sexual behavior (mount-
ing) and libido as were observed in YAC72 / mice
and YAC72 / mice. Similar plug-formation rates
were obtained for males of all three genotypes. Plugs
were recovered in 8 of 12 breeding trials for YAC72 /
 mice, in 7 of 12 breeding trials for YAC72 /mice,
and in 8 of 16 breeding trials for YAC72 / mice. In
sharp contrast to both YAC72 / mice and YAC72
/ mice, no postcoital sperm was ever recovered from
plugged females after mating with YAC72 / mice.
These results suggested that a defect in spermatogene-
sis—and not in breeding behavior—was responsible for
the observed lack of fertility of male YAC72 / mice.
Decreased Fertility in Mice Expressing Mutant htt: A
Result of Decreased Sperm Production
To assess spermatogenesis directly in YAC72 /
mice, we performed sperm counts and examined the tes-
tes of these mice. At age 4 mo, YAC72 / mice had
significantly decreased epididymal sperm counts com-
pared with YAC72 / mice (11 # 103/ml  2.9/ml
vs. 13 # 105/ml  100/ml ; ) or YAC72P ! .00001
/ mice (11 # 103/ml  2.9/ml vs. 14 # 105/ml 
65/ml; ) littermates (fig. 1D).P ! .00001
Testicular Atrophy and Spermatid Degeneration in
Mice Expressing Mutant htt
At age 4 mo, YAC72 / mice had significant tes-
ticular atrophy compared with YAC72 / mice (av-
erage testes weight 54.0 mg 2.9 vs. 84.7 mg 3.6.9;
) and YAC72 / mice (average testesP ! .00001
weight 54.0 mg  2.9 vs. 90.1 mg  3.0; )P ! .00001
littermates (fig. 1E).
Histological examination of sections from the testes of
adult mice expressing expanded mutant htt (YAC46/
or YAC72/) stained with toluidine blue revealedmas-
sive disruption of spermatogenesis in the seminiferous tu-
bules. The seminiferous tubules from these mice were full
of large vacuoles and dying cells (fig. 2A and D), but the
spermatagonial stem cells and Sertoli cells close to the
basement lamina appeared relatively normal in appear-
ance and number. Depletion—but not absence—of cells
at later stages of spermatogenesis (spermatocytes and
spermatids) was evident in all layers of degenerating tu-
bules. Degenerating cells at various stages of development
were identified, suggesting that the spermatogenic defect
caused by mutant htt is not either limited to a single stage
of development or due to defective maturation of sper-
matocytes. The normal stratified organization of cells
within these seminiferous tubules was completely dis-
rupted. Rarely, late spermatids were identified in the outer
cell layer, but mature spermatozoa were not found in the
lumen of these tubules, which were often filled with cel-
lular debris (fig. 2A and D). Leydig cells appeared to be
unaffected in the stromal interstitial tissue between de-
generating tubules.
Cellular Degeneration in Mice Expressing Mutant htt:
Blockage by Expression of Endogenous htt and
Dependence on CAG Length
This testicular degeneration was most striking in the
testes of YAC72 / mice (fig. 2A). Occasionally, vac-
uolization and cellular degeneration were seen in the
testes of YAC72 / mice expressing 50% of endoge-
nous htt levels (fig. 2B), but these mice were able to
produce mature sperm (fig. 1E). Increasing the endog-
enous htt expression to 100% of normal levels in YAC72
mice completely rescued the degenerative testicular phe-
notype (fig. 2C). Normal stratified organization was re-
stored to the seminiferous tubules, and neither vacuoli-
zation nor an increased number of degenerating cellswas
present. Mature spermatozoa were found in the lumen
of seminiferous tubules of YAC72 / mice (fig. 2C,
arrow), and these mice had normal fertility. These results
suggest that the testicular cell death caused by the ex-
pression of polyglutamine-expanded htt in transgenic
mice could be completely blocked by an increase in the
level of endogenous htt.
The testicular cell death caused by the expression of
polyglutamine-expanded htt in transgenic mice (YAC46
/ or YAC72 /) does not occur in mice expressing
the same human transgene without the CAG-repeat ex-
pansion (YAC18 / mice; fig. 2G). YAC18 mice lack-
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Figure 2 Testicular morphology of YAC transgene–rescued Hdh-nullizygous mice. Semithin sections of testes stained with toluidine blue
that are from 8-mo-old mice reveal the gross testicular morphology of mice with the YAC72 (A–C), YAC46 (D–F), and YAC18 (G–I) HD
transgenes and either complete absence of endogenous htt (/), 50% of endogenous htt levels (/), or 100% of endogenous htt levels (/
). Massive degeneration of spermatogenic cells occurs in the seminiferous tubules of mice expressing mutant htt with either 46 or 72
polyglutamine repeats (A and D). The cell death is most pronounced in YAC72 / (A), intermediate in YAC46 / (D), and not present in
YAC18 / (G) Hdh-nullizygous mice. The human HD transgene in each of these lines of mice is identical except for the length of the CAG
repeat, and these results suggest that this novel cell-death phenotype is CAG-repeat-length dependent. Increasing levels of endogenous htt
markedly reduced the amount of spermatogenic-cell degeneration (B, C, E, and F) observed in YAC46 and YAC72 mice. (Scale bar p 100
mm)
ing endogenous htt had normal morphology of the sem-
iniferous tubules, no evidence of increased testicular cell
death, and normal fertility. No significant effect on
YAC18 mice was seen when levels of endogenous htt
were increased to 50% or 100% of the normal htt levels
(fig. 2H and I).
Histological examination of toluidine blue–stained
sections from the testes of adult mice expressing mutant
htt revealed massive cellular death in multiple layers of
the seminiferous tubules (fig. 3A). TUNEL labeling (fig.
3B, arrows) confirmed the apoptotic nature of the wide-
spread cell death in the testes of YAC72 / mice. De-
spite the drastically reduced numbers of cells within sem-
iniferous tubules of testes of YAC72 / mice, the
average number of TUNEL-positive cells (3.2 per low-
power [20#] field) was ∼10-fold higher in these sections
than in sections of testes of YAC72/mice containing
normal numbers of spermatogenic cells (0.3 per 20#
field). No increased testicular cell death was observed in
YAC72 mice expressing 100% of normal levels of en-
dogenous htt (YAC72 /), either by toluidine blue
staining (fig. 3C) or by TUNEL labeling (fig. 3D).
Ultrastructural analysis (by electron microscopy) of
the testes in YAC72 mice nullizygous for endogenous
htt (/) revealed large numbers of degenerating sper-
matids with diffuse cytoplasmic vacuolization (fig. 3E).
Shrunken degenerating spermatids, with condensed nu-
clei and electron-dense cytoplasm, were phagocytosed
and degraded by Sertoli cells (fig. 3F), suggesting on-
going apoptosis and confirming our TUNEL findings.
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Figure 3 Morphological, biochemical, and ultrastructural evidence for apoptotic cell death in the testes of YAC72mice lacking endogenous
htt. Toluidine blue staining revealed massive death of spermatogenic cells in the testes of YAC72/mice. Decreased numbers of spermatogenic
cells and a disordered epithelium filled with vacuoles are present in these testes, compared with the very large numbers of spermatocytes in the
well-ordered stratified epithelium of testes of YAC72 / mice. Increased apoptosis was evident in the testes of YAC72 / mice, on the basis
of increased TUNEL labeling of spermatogenic cells (B, arrows), compared with YAC72 mice that had normal levels of endogenous htt (D).
EM analysis of degenerating testicular cells from YAC72 / mice also provided evidence of apoptosis. Ultrastructural analysis of testes from
Hdh- nullizygous YAC72 mice reveals massive cell death of spermatids, phagocytosis of degenerating cells, and formation of multinucleated
giant cells. The epithelium of YAC72 mice lacking endogenous htt was characterized by degenerating spermatids filled with cytoplasmic vacuoles
(E), phagosomes containing shrunken electron-dense spermatids engulfed within Sertoli cells (F), and spermatogenic giant cells (G). (Scale bars
in A–D p 100 mm; scale bar in E p 10 mm; scale bar in F p 5 mm; scale bar in G p 10 mm)
Multinucleated giant cells were found throughout the
testes of YAC72 / mice. These cells result from the
opening of intercellular bridges between clones of sper-
matogenic cells. Importantly, no such degenerative phe-
notype was found by ultrastructural analysis of the testes
of YAC18 mice (data not shown).
Abnormal Protein Aggregates: Occurrence in the
Testes of Mice Expressing Mutant htt
Ultrastructural analysis of the testes of YAC72 /
mice revealed the presence of occasional abnormal ag-
gregates of intracellular protein (fig. 4A–C, arrowheads)
within spermatids (fig. 4A), Sertoli cells (fig. 4B), and
sperm tails (fig. 4C). These aggregates were rare and
were found at an incidence of much less than one per
high-powered field. No protein aggregates were identi-
fied in YAC18 / mice (data not shown). Ectopic mi-
crotubule bundles (fig. 4D) and manchettes (fig. 4E)
were also occasionally identified (fig. 4D and E, arrow-
heads) within spermatogonia and spermatids, respec-
tively. Also interesting is the observation that actin-con-
taining adhesion plaques (ectoplasmic specializations)
that occur in Sertoli-cell cortical cytoplasm in regions of
adhesion to spermatids often occurred in ectopic posi-
tions. Normally these structures occur only in regions
of attachment to spermatid heads. In Sertoli cells of
YAC72 / mice, ectoplasmic specializations were ob-
served to completely surround elongate spermatids that
had reacquired a circular form (data not shown).
Immunocytochemical analysis of htt localization in
the testes of YAC72 / mice revealed that protein ag-
gregates within a small number of degenerating sper-
matids (fig. 5A and B) contain htt. Similar htt immu-
noreactivity was identified in aggregates within Sertoli
cells adjacent to the basal lamina of degenerating sem-
iniferous tubules (fig. 5C and D). Labeling of filamen-
tous actin by fluorescent phallotoxin revealed altered
localization of filaments within the testes of YAC72
/ mice (fig. 5I and J). In YAC72 / mice (fig. 5E
and F), actin filaments were concentrated in Sertoli-cell
adhesion plaques (ectoplasmic specializations) found ap-
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Figure 4 Protein aggregates in YAC72 / mice. Ultrastructural analysis of the testes of YAC72 mice lacking endogenous htt revealed
the occasional presence of abnormal aggregates of intracellular protein (arrowheads) within elongate spermatids (A), Sertoli cells (B), and sperm
tails (C). The composition of these protein aggregates is not entirely clear, but they resemble the ultrastructural appearance of htt aggregates
found in human HD brain tissue. Ectopic microtubule bundles (D) and manchettes (E) also were identified (asterisks [*]). The bundle in panel
E is in a spermatogonium. N p nucleus. (Scale bars in A and B p 5 mm; scale bar in C and D p 1 mm; scale bar in E p 5 mm)
ically in association with spermatid heads and basally
in association with junction complexes between neigh-
boring Sertoli cells. In tissue of YAC72 / mice (fig.
5I and J), actin filaments occur in linear arrays perpen-
dicular to the tubule wall and in areas not directly related
to spermatid heads (fig. 5J, arrows with asterisks).
Discussion
In this article, we have provided evidence that wild-type
htt can significantly reduce the cellular toxicity ofmutant
htt in vivo. Expression of human htt with an expanded
polyglutamine tract (46 and 72 polyglutamines) in the
absence of wild-type htt results in male infertility and in
massive apoptotic cell death in the testes in all phases
of spermatogenesis. The cell death can be modulated by
the expression of normal htt. For example, mice ex-
pressing human htt with either 46 or 72 polyglutamines
have no evidence of testicular atrophy or apoptosis in
the testes when wild-type htt is expressed from bothHdh
alleles. An intermediate phenotype is seen in these mice
(YAC46 and YAC72), on the background of heterozy-
gosity for targeted disruption in the mouse Hdh gene
(YAC46 / or YAC72 /). The severity of the tes-
ticular atrophy and apoptotic cell death is also modu-
lated by the length of the polyglutamine repeat. To pre-
vent testicular degeneration, YAC72 transgenic mice
require higher levels of wild-type htt (/) than do
YAC46 transgenic mice (/). Abnormal protein ag-
gregates, which contain htt, are occasionally found both
in Sertoli cells and in spermatogenic cells in the testis of
YAC72 / mice. Also, structures containing cytoske-
letal elements form ectopically in these mice, suggesting
that alterations either in the targeting of cytoskeletal
elements to specific positions in the cells or of cytoske-
letal function may be a mechanism promoting the mas-
sive apoptosis observed. These findings suggest that dis-
ruption of normal cytoskeletal organization may play a
role in mediation of the toxic effect of mutant htt.
These findings may have relevance to the pathogenesis
of HD. Interestingly, both mutant and wild-type htt pro-
teins undergo cleavage (Wellington et al. 1998) and are
recruited and sequestered into htt aggregates, leaving
less-full-length wild-type htt available to counteract
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Figure 5 Immunocytochemical analysis of protein aggregates and actin distribution in sections from the testes of YAC72 / mice.
Abnormal protein aggregates within degenerating spermatogenic cells in the testes of YAC72 / mice contain htt (phase [A] and immuno-
fluorescence [B]). In normal epithelium (phase [E] and fluorescence [F]), actin filaments in Sertoli cells are concentrated in unique adhesion
plaques (ectoplasmic specializations) that occur at apical sites of attachment to spermatids (Apical) and at basal sites of attachment to neighboring
Sertoli cells (Basal). In YAC72 / mice (G–J), filament bundles (asterisks [*]) in apical regions occur in areas not associated with spermatid
heads, although filament bundles at basal sites occur in their normal position. (Scale bars in A–D p 10 mm; scale bars in E–J p 50 mm)
proapoptotic stimuli (Martindale et al. 1998). Polyglu-
tamine expansion in one allele of the HD gene is as-
sociated with expression of half the cellular levels of
wild-type htt compared with that in normal neurons,
which, together with htt cleavage and sequestration of
wild-type htt in aggregates, may further decrease func-
tional htt levels. Mice heterozygous for targeted dis-
ruption of the Hdh gene express half the normal levels
of wild-type htt and, elsewhere, have been shown to
develop neuronal degeneration in the basal ganglia (Na-
sir et al. 1995; O’Kusky et al. 1999). One of the normal
functions of htt in the brain may be to protect cells
against proapoptotic stimuli, and partial loss of this
function may underlie some of the selective vulnerability
of striatal neurons to cell death in HD. These data sup-
port our previously published hypothesis that loss of
function of wild-type htt may also contribute to the
pathogenesis of HD (Nasir et al. 1995).
We have also recently demonstrated that wild-type
human htt can protect hippocampal neurons from
kainic acid–induced excitotoxicity (B. R. Leavitt, J. van
Raamsdonk, J. G. Hodgson, C. L. Wellington, and M.
R. Hayden, unpublished data). Furthermore, the very
recent report that inactivation of Hdh expression in
adult mice is associated with progressive apoptotic neu-
rodegeneration provides further support for the anti-
apoptotic role of wild-type htt in the adult brain (Dra-
gatsis et el. 2000).
A number of observations indicate that the ultimate
outcome of htt toxicity in the testis is the apoptotic loss
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of spermatogenic cells. The dramatic vacuolization
within the seminiferous tubules, the TUNEL staining of
spermatogenic cells, and the ectopic positioning of man-
chettes (microtubule structures associated with sper-
matid nuclei) in these cells are consistent with this con-
clusion. The presence of giant cells in the epithelium;
the occurrence, in Sertoli cells, of large phagosomes con-
taining spermatids; and the obviously reduced numbers
of spermatogenic cells in the epithelium, demonstrated
by our EM analysis—all point to the conclusion that
the primary testicular phenotype in YAC72 / mice
is apoptotic death of spermatogenic cells, particularly
of spermatids.
Although morphological changes and cell loss are
most dramatic in the spermatogenic-cell population in
the testes of YAC72 / mice, Sertoli cells also express
abnormal features. Two of these features are the pres-
ence of protein aggregates in the cytoplasm and the
ectopic positioning of actin filament–containing junc-
tion plaques normally found in regions adjacent to
spermatid heads. Abnormal positioning of ectoplasmic
specializations adjacent to spermatid cells may be a re-
sponse to a primary defect in the associated spermat-
ogenic cells. The presence of normally positioned junc-
tion plaques in basal regions of attachment to
neighboring Sertoli cells is consistent with this conclu-
sion. These findings suggest that mutant htt causes an
intrinsic polyglutamine-mediated apoptotic cell death
within spermatogenic cells, which can be blocked by
wild-type htt.
Elsewhere, we have shown that human htt can com-
pensate for the critical function of murine htt during
gastrulation, by rescuing mice with targeted disruption
on both Hdh alleles (Hodgson et al. 1996). These mice
are rescued by both normal htt (YAC18) and mutant
htt (YAC46 and YAC72), clearly indicating that ex-
pansion of the polyglutamine does not disturb this im-
portant role of htt in development. In the present study,
we have provided further evidence for cross-species
functional complementarity of htt. The presence of mu-
rine htt can completely protect cells against the proap-
optotic effects of mutant human htt. Cross-species func-
tional complementation between mouse htt and human
htt, in both development and protection against apopto-
sis, must reflect their high degree of sequence conser-
vation, with mouse htt and human htt sharing complete
identity of nucleotides at a level of 90% similarity in
amino acid structure (Lin et al. 1994).
The data in the present article provide strong in vivo
evidence that wild-type htt can significantly modulate
the apoptotic toxicity of mutant htt, and we suggest
that wild-type htt may normally have an antiapoptotic
function. Both mapping of the htt critical region re-
sponsible for this function and investigation of the
mechanism by which this critical region influences cell-
death pathways may identify novel therapeutic targets
for HD and advance our understanding of htt’s normal
role in the delicate balance between life and death in
cells.
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